Average Co-Inventor Count = 5.61
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Actelion Pharmaceuticals Ltd (43 from 217 patents)
2. Idorsia Pharmaceuticals Ltd (16 from 77 patents)
59 patents:
1. 11839613 - Pyrimidine derivatives as PGE2 receptor modulators
2. 11712438 - Phenyl derivatives as PGE2 receptor modulators
3. 11446298 - Pyrimidine derivatives
4. 11325899 - Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
5. 11267824 - Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
6. 11136317 - NADPH oxidase 4 inhibitors
7. 11040966 - Benzimidazole-proline derivatives
8. 10584118 - NADPH oxidase 4 inhibitors
9. 10351560 - Crystalline forms
10. 10329287 - Benzimidazole-proline derivatives
11. 10301309 - Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
12. 10023560 - Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
13. 9914720 - Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
14. 9914721 - Use of benzimidazole-proline derivatives
15. 9879006 - [object Object]